tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Corbus Pharmaceuticals Receives FDA Fast Track Designation
PremiumCompany AnnouncementsCorbus Pharmaceuticals Receives FDA Fast Track Designation
1M ago
Corbus Pharmaceuticals reports Q2 EPS ($1.44), consensus ($1.33)
Premium
The Fly
Corbus Pharmaceuticals reports Q2 EPS ($1.44), consensus ($1.33)
1M ago
Corbus Pharmaceuticals transferred with Buy rating at B. Riley
Premium
The Fly
Corbus Pharmaceuticals transferred with Buy rating at B. Riley
1M ago
Buy Rating for Corbus Pharmaceuticals’ CRB-701: Promising Efficacy and Safety in Oncology
PremiumRatingsBuy Rating for Corbus Pharmaceuticals’ CRB-701: Promising Efficacy and Safety in Oncology
3M ago
Corbus Pharmaceuticals Appoints New Chair of the Board
Premium
Company Announcements
Corbus Pharmaceuticals Appoints New Chair of the Board
4M ago
Corbus Pharmaceuticals appoints Jacques as Chair of Board of Directors
Premium
The Fly
Corbus Pharmaceuticals appoints Jacques as Chair of Board of Directors
4M ago
Corbus Pharmaceuticals Advances Clinical Pipeline Amid Q1 Loss
PremiumCompany AnnouncementsCorbus Pharmaceuticals Advances Clinical Pipeline Amid Q1 Loss
4M ago
Corbus Pharmaceuticals Receives FDA Fast Track Designation
Premium
Company Announcements
Corbus Pharmaceuticals Receives FDA Fast Track Designation
4M ago
Corbus Pharmaceuticals reports Q1 EPS ($1.39), consensus ($1.07)
Premium
The Fly
Corbus Pharmaceuticals reports Q1 EPS ($1.39), consensus ($1.07)
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100